| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 20.47M | — |
| Operating expense | — | — |
| Net income | 5.22M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, IRMD returned +22.8% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -9.0% |
| 1 year | +22.8% |
| 5 years | +187.0% |
| 10 years | +419.0% |
| All-time high | $103.53 (Feb 2026) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in IRMD would be worth today ›Yes. IRADIMED CORPORATION paid 5 dividends over the past 12 months. The most recent was $0.20 per share on Aug 14, 2026. The dividend yield is 0.91%.
IRADIMED CORPORATION stock trades on NASDAQ under the ticker symbol IRMD.
IRADIMED CORPORATION is part of the Healthcare sector.
IRADIMED CORPORATION has a market cap of 1.13B USD, based on the latest quote.
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.
